Likely varicella; manage as contagious VZV now while urgently testing for orthopox if red flags exist.
Recommendation
- Isolate immediately and treat as varicella (chickenpox) with standard/contact and airborne precautions; obtain rapid PCR testing for VZV from a fresh vesicle AND orthopoxvirus PCR if lesions are monomorphic, umbilicated, deeply necrotic, involve palms/soles, or there’s high‑risk animal contact. Start oral acyclovir if child is ≥12 years, has chronic skin/pulmonary disease, is on salicylates/steroids, or presents within 24 hours of rash onset; give VZV post‑exposure prophylaxis to susceptible high‑risk contacts. 1
Rationale focused on morbidity, mortality, QOL
- Household secondary attack rate for varicella is 80–90% and secondary cases are often more severe; contagious from 1–2 days before rash until crusting—rapid spread to a household contact in 24 h fits VZV far better than zoonotic orthopoxviruses, which typically evolve over days and are less explosively transmissible in households 1.
- Timely isolation and prophylaxis prevent severe disease in pregnant, immunocompromised, and adult contacts, reducing complications and mortality 1.
Distinguishing features to decide on orthopox PCR add‑on
- Favors varicella: lesions in multiple stages simultaneously (macules, papules, vesicles, crusts), centripetal distribution, quick household spread, pruritic more than painful 2, 1.
- Favors zoonotic orthopox (e.g., mpox/cowpox): lesions all in same stage, umbilicated/deeply necrotic, painful with marked lymphadenopathy, exposure to sick rodents/exotic mammals/cats; slower evolution over days, often localized starting at inoculation site (face/hands) 2, 3. Cowpox classically painful necrotic lesions after cat exposure; confirm by PCR if suspected 4.
- Smallpox is eradicated; do not consider as cause of current community rash illnesses 5.
Immediate management algorithm
- Infection control now
- Home isolation of cases until all lesions crust. Separate bedroom/bath if possible; no school/daycare. Mask if any coughing; cover lesions 1.
- Diagnostic testing today
- Antiviral therapy (to reduce complications)
- Start oral acyclovir (within 24 h of rash onset) for: adolescents ≥12 y, chronic cutaneous/pulmonary disease, on long‑term salicylates, on steroids, or severe/pruritic extensive disease; typical pediatric dosing per standard references. Supportive care for others (antipyretics, antihistamines; avoid aspirin) 1.
- Post‑exposure prophylaxis for contacts (do now)
- Varicella vaccine within 3–5 days of exposure for susceptible, immunocompetent contacts to prevent/attenuate disease.
- VariZIG for high‑risk susceptible contacts (pregnant, immunocompromised, certain neonates) as soon as possible within 10 days; if VZIG unavailable/late, consider antivirals per local protocol. These steps avert severe morbidity and mortality 1.
- Escalate care/ED if any danger signs
- Respiratory distress, neurologic symptoms, severe dehydration, or rapidly progressive/hemorrhagic rash (higher risk of complications) 1.
- Infection control now
Pitfalls and how to avoid them
- Mistaking rapid household transmission for mpox—mpox spreads less explosively in households; don’t delay VZV isolation/prophylaxis while waiting for orthopox testing 1, 2.
- Assuming vaccine history rules out chickenpox—breakthrough varicella occurs and is contagious; still isolate and manage as VZV 1.
- Using aspirin in children—risk of Reye syndrome; use acetaminophen/ibuprofen instead 1.
- Missing severe secondary cases in the home—these are often worse than index; monitor closely and treat early 1.
Why this decision
- The strongest and most applicable guidance (Pediatrics varicella prevention recommendations) emphasizes VZV’s very high household transmissibility, typical clinical timeline, contagious window, and actionable prophylaxis/management—key to reducing complications and mortality. Orthopox literature supports targeted testing when lesion morphology/exposure suggests it, but default management for rapid household spread is VZV-focused 1, 2.